Research News and Research

RSS

Lamictal can cause aseptic meningitis: FDA

The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk.

13 Aug 2010

Eli Lilly to appeal against U.S. District Court ruling in Strattera patent litigation

Eli Lilly and Company today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its patent litigation for Strattera. In the case of Eli Lilly and Company v. Actavis Elizabeth LLC, et al, the court ruled that Lilly's '590 patent, or method-of-use patent, for Strattera is invalid. The patent had been set to expire in May of 2017.

13 Aug 2010

DNA repair genes in melanoma tumours repair associated with poor response to chemotherapy: Research

A Link between the level of active DNA repair genes in melanoma tumours and the effectiveness of chemotherapy for skin cancer patients has been established for the first time by a team of scientists.The study, part-funded by Cancer Research UK and published in Clinical Cancer Research today (Friday), found that higher levels of DNA repair genes in melanoma tumours were associated with a poorer response to chemotherapy.

13 Aug 2010

Hana Biosciences second-quarter net loss decreases to $6.3 million

Hana Biosciences Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the three and six months ended June 30, 2010, and provided a corporate update.

13 Aug 2010

Research reveals self-care improves healing experience

New research conducted by Experience In Motion LLC (EIM), Minneapolis, reveals that when healthcare organizations, their staff and practitioners engage in self-care as an organizational strategy, it not only improves the healing experience for themselves and patients, but it also improves business measures.

13 Aug 2010

Women's eNews examines recent global focus on women farmers

Women's eNews looks at how women farmers are receiving more international recognition for their role in agriculture.

13 Aug 2010

Mount Sinai receives grant from NIH to continue research on food allergy

Mount Sinai School of Medicine today announced that the National Institutes of Health (NIH) has renewed its funding of the Consortium of Food Allergy Research (CoFAR), providing an additional $29.9 million toward genetic research and the prevention and treatment of food allergy. Mount Sinai is the primary research site for CoFAR, leading seven other institutions around the country.

13 Aug 2010

U.S.-funded center to improve Haitian garment manufacturing opens in Haiti

The U.S.-funded Haitian Apparel Center, which aims to train about 2,000 workers per year, was opened in the capital of Port-au-Prince on Wednesday, the Associated Press reports. The new center will help Haitian companies evolve from making "simple things, like sheets and T-shirts, to more complex garments," according to U.S. Ambassador Kenneth Merten. "And more complex garments mean higher profit margins and more money coming into the country," he added (Lush, 8/11).

13 Aug 2010

Combination of fungi, insecticides can combat malaria mosquitoes: Research

A combination of fungal spores and chemical insecticides are an effective way of combating insecticide-resistant malaria mosquitoes. Researchers at Wageningen UR and from Benin, West Africa, have shown that fungi and insecticides reinforce each other´s efficacy, and that the effect of using a combination of both is greater than the sum of using the two methods separately. Their article in the August edition of PLoS One (Public Library of Science) claims that biological and chemical methods of fighting malaria can and should be used together.

13 Aug 2010

NewCardio second-quarter net loss decreases to $1.5 million

NewCardio, Inc., a cardiac diagnostic technology provider, today announced financial results for the second quarter ended June 30, 2010.

13 Aug 2010

Study identifies use of acetaminophen may increase asthma symptoms in adults

New evidence linking the use of acetaminophen to development of asthma and eczema suggests that even monthly use of the drug in adolescents may more than double risk of asthma in adolescents compared to those who used none at all; yearly use was associated with a 50 percent increase in the risk of asthma.

13 Aug 2010

Floods: U.N. issues $459.7M appeal for Pakistan, China concerned about disease outbreaks after mudslides

The U.N. appealed for $459.7 million on Wednesday "to aid flood victims in Pakistan as the magnitude of the disaster widened, with about one-fifth of the country submerged and the annual monsoon season still potent," the New York Times reports (MacFarquhar, 8/11).

13 Aug 2010

AHRQ selects Outcome Sciences to study effects of different treatments for open angle glaucoma

Outcome Sciences, Inc. (OUTCOME), the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, today announced that the Agency for Healthcare Research and Quality (AHRQ) has selected Outcome as the DEcIDE Center for a study designed to compare the effectiveness of medications versus surgery for the treatment of open-angle glaucoma. The study will enroll 2,600 patients from 30 sites across the United States and is intended to provide new scientific information about the effects of different treatment approaches in individuals who have glaucoma.

13 Aug 2010

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

In a move likely to secure its place as a leading provider of medical radiation countermeasures, Humanetics Corporation today announced that it has secured exclusive worldwide licenses to two new treatments that provide short and long-term post-exposure protection from ionizing radiation acquired during a terrorist act, nuclear or radiological attack or accident, as part of cancer radiotherapy or even during routine diagnostic CT scans.

13 Aug 2010

Companies reorganizing under Chapter 11 battle with former employees over lifetime health benefits

The Wall Street Journal: "Linda Roberts thought she would enjoy lifetime health benefits after a dozen years lifting radiators and iron in a factory for Visteon Corp. But the car-parts maker won bankruptcy-court approval to terminate those retiree benefits, just months after Ms. Roberts, 62 years old, was diagnosed with multiple myeloma and leukemia.

13 Aug 2010

Researchers develop new implantable metamaterials to destroy cancerous tissue

The research, reported online July 21, 2010, in the journal Advanced Materials, provides a promising path towards the development of a new class of metamaterial-inspired implantable biosensors and biodetectors.Metamaterials are artificial electromagnetic composites, typically made of highly conducting metals, whose structures respond to electromagnetic waves in ways that atoms in natural materials do not. The most futuristic metamaterials would absorb all light, to create heat to destroy cancerous tissue, or bend light completely around an object, rendering that object invisible-an imaginary delight for fans of science fiction or spy novels.

13 Aug 2010

A*STAR's Singapore Immunology Network, Institut M-rieux and bioM-rieux partner in TB research

An investment of S$3 million is being pumped into tuberculosis (TB) research by A*STAR's Singapore Immunology Network (SIgN), bioindustrial group Institut M-rieux and its in vitro diagnostics company bioM-rieux. The project, which involves setting up a joint laboratory in Biopolis, Singapore aims to investigate and identify novel biomarkers that could allow early identification of individuals at risk of TB disease development and disease reactivation. This could lead to better diagnosis and treatment for the highly contagious disease.

13 Aug 2010

Kibow to support KDAE week for educating policymakers about kidney disease

Kibow Biotech would like to show its support for Kidney Disease Awareness and Education (KDAE) Week 2010, organized by American Nephrology Nurses' Association (ANNA). Kidney Disease Awareness and Education Week is a week dedicated to educating policymakers and their staff members about the needs of patients suffering from or at risk for end stage renal disease (ESRD).

13 Aug 2010

NovaBay second-quarter net loss increases to $1.2 million

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported second quarter financial results and highlighted the clinical progress of its in-house programs.

13 Aug 2010

Gore announces first implantation in IDE clinical study of ACUSEAL Vascular Graft in hemodialysis patients

W. L. Gore & Associates reported that the first patient, in an Investigational Device Exemption (IDE) clinical study evaluating the self sealing GORE® ACUSEAL Vascular Graft in patients on hemodialysis, has been surgically implanted with the device. The successful surgical procedure was performed on July 29, 2010 at Greenville Hospital System in Greenville, South Carolina. Less than 24 hours after the device was implanted it was successfully cannulated or punctured for initial hemodialysis access.

13 Aug 2010

Research News and Research

Lamictal can cause aseptic meningitis: FDA

Eli Lilly to appeal against U.S. District Court ruling in Strattera patent litigation

DNA repair genes in melanoma tumours repair associated with poor response to chemotherapy: Research

Hana Biosciences second-quarter net loss decreases to $6.3 million

Research reveals self-care improves healing experience

Women's eNews examines recent global focus on women farmers

Mount Sinai receives grant from NIH to continue research on food allergy

U.S.-funded center to improve Haitian garment manufacturing opens in Haiti

Combination of fungi, insecticides can combat malaria mosquitoes: Research

NewCardio second-quarter net loss decreases to $1.5 million

Study identifies use of acetaminophen may increase asthma symptoms in adults

Floods: U.N. issues $459.7M appeal for Pakistan, China concerned about disease outbreaks after mudslides

AHRQ selects Outcome Sciences to study effects of different treatments for open angle glaucoma

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

Companies reorganizing under Chapter 11 battle with former employees over lifetime health benefits

Researchers develop new implantable metamaterials to destroy cancerous tissue

A*STAR's Singapore Immunology Network, Institut M-rieux and bioM-rieux partner in TB research

Kibow to support KDAE week for educating policymakers about kidney disease

NovaBay second-quarter net loss increases to $1.2 million

Gore announces first implantation in IDE clinical study of ACUSEAL Vascular Graft in hemodialysis patients

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence